Abstract
Gastric cancer (GC) is a serious fatal cancer on a global scale because of its presentation at advanced stage. The expressions of vascular endothelial growth factor (VEGF), E-cadherin, and matrix metalloproteinases (MMPs) in other cancers have been reported. However, its expression and underlying mechanisms are little known in gastric cancer in Indian context. In this study, we detected mRNA expression of VEGF, E-cadherin, and MMPs (MMP-1, MMP-2, and MMP-9) in 73 gastric cancer tissues and 27 normal controls by reverse-transcriptase polymerase chain reaction (RT-PCR). Receiver operator characteristics analysis was done for determining the diagnostic utility of VEGF, MMPs and E-cadherin with respect to the sensitivity and specificity. The association of VEGF, MMPs, and E-cadherin expression with the clinicopathological characteristics and the prognosis was subsequently analyzed. The mRNA expression results showed that E-cadherin was significantly downregulated in 47.9% of GC in comparison to control. There was no change in VEGF expression observed in 90.4% GC cases. MMP-1, MMP-2, and MMP-9 were overexpressed in 13.7%, 28.8%, and 11% of GC, respectively, with significant change in MMP-2 (p ≤ 0.0001) and MMP-9 (p = 0.027) in comparison to control. Our results strengthen the necessity of more studies to elucidate the prophetic role of these genes in the development of gastric cancer.


Similar content being viewed by others
References
Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP (2018) Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 10:239–248. https://doi.org/10.2147/CMAR.S149619
Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, Risk Factors, Screening, and Prevention. Cancer Epidemiol Biomarkers Prev 23(5):700–713
Murugesan CS, Manickavasagam K, Chandramohan A, Jebaraj A, Jameel ARA, Jain MS, Venkataraman J (2018) Gastric cancer in India: epidemiology and standard of treatment. Updat Surg 70:233–239
Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (2011) SEER cancer statistics review, 1975-2008. National Cancer Institute, Bethesda Based on November 2010 SEER data submission, Posted to the SEER Web Site
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423–1437
Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011–1027
Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 77:858–863
Shiozaki H, Oka H, Inoue M, Tamura S, Monden M (1996) E-cadherin mediated adhesion system in cancer cells. Cancer 77:1605–1613
Wong SHM, Fang CM, Chuah LH, Leong CO, Ngai SC (2018) E-cadherin: its dysregulation in carcinogenesis and clinical implications. Crit Rev Oncol Hematol 121:11–22
Zhou Y, Li G, Wu J, Zhang Z, Wu Z, Fan P, Hao T, Zhang X, Li M, Zhang F, Li Q, Lu B, Qiao L (2010) Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumour Biol 31(6):549–558
Bure IV, Nemtsova MV, Zaletaev DV (2019) Roles of E-cadherin and noncoding RNAs in the epithelial-mesenchymal transition and progression in gastric cancer. Int J Mol Sci 20(12):E2870. https://doi.org/10.3390/ijms20122870
Kubben FJGM, Sier CFM, van Duijn W, Griffioen G, Hanemaaijer R, van de Velde CJ, van Krieken JH, Lamers CB, Verspaget HW (2006) Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer 94:1035–1040
Kahari VM, Saarialho-Kere U (1999) Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31:34–45
Shin DH, Dier U, Melendez JA, Hempel N (2015) Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells. Biochim Biophys Acta 1852:2593–2602
Ozden F, Saygin C, Uzunaslan D, Onal B, Durak H, Aki H (2013) Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival. J Cancer Res Clin Oncol 139(8):1373–1382. https://doi.org/10.1007/s00432-013-1453-x
Cai QW, Li J, Li XQ, Wang JQ, Huang Y (2012) Expression of STAT3, MMP-1 and TIMP-1 in gastric cancer and correlation with pathological features. Mol Med Rep 5:1438–1442
Kumar V, Abbas A, Fausto N, Robbins C (2010) Pathologic basis of disease, 8th edn. Elsevier Printed in China, Copyright, pp 62–63 82, 206–209,302–303, 328–331
Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12(3):354–362
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249
Shibuya M (2015) VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets 15(2):135–144
Park SH, Lee SS (2003) The relationship between serum VEGF concentration and prognosis of lung cancer. Korean J Intern Med 18(4):207–211
Schizas D, Moris D, Michalinos A, Kanavidis P, Oikonomou D, Papalampros A, Machairas A, Liakakos T (2017) E-cadherin in gastric carcinomas: relations with histological parameters and its prognostic value. J BUON 22(2):383–389
Czyzewska J, Guzinska-Ustymowicz K, Ustymowicz M, Pryczynicz A, Kemona A (2010) The expression of E-cadherin- catenin complex in patients with advanced gastric cancer: role in formation of metastasis. Folia Histochem Cytobiol 48:37–45
Stanculescu D, Margaritescu C, Stepan A, Mitrut AO (2011) E-cadherin in gastric carcinomas related to histological prognostic parameters. Romanian J Morphol Embryol 52(3 Suppl):1107–1112
Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM (2002) Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 8:987–993
Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL (2003) Promoter methylation of E-cadherin gene in gastric mucosa associated with helicobacter pylori infection and in gastric cancer. Gut 52:502–506
Guzman P, Araya J, Villaseca M, Roa I, Melo A, Muñoz S, Roa J (2006) Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer. Rev Med Chil 134:1002–1009 (Abstract)
Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27:6920–6929
Anbiaee R, Mojir Sheibani K, Torbati P, Jaam H (2013) Abnormal expression of e-cadherin in gastric adenocarcinoma, and its correlation with tumor histopathology and helicobacter pylori infection. Iran Red Crescent Med J 15:218–222
Karayiannakis AJ, Syrigos KN, Chatzigianni E, Papanikolaou S, Karatzas G (1998) E-cadherin expression as a differentiation marker in gastric cancer. Hepatogastroenterology 45:2437–2442
Ohno T, Aihara R, Kamiyama Y, Mochiki E, Asao T, Kuwano H (2006) Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer. Eur J Cancer 42:256–263
Lee MY, Chou CY, Tang MJ, Shen MR (2008) Epithelial–mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail upregulation. Clin Cancer Res 14:4743–4750
Hauff SJ, Raju SC, Orosco RK, Gross AM, Diaz-Perez JA, Savariar E, Nashi N, Hasselman J, Whitney M, Myers JN, Lippman SM, Tsien RY, Ideker T, Nguyen QT (2014) Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice. Otolaryngol Head Neck Surg 151(4):612–618
Liu LQ, Chen ZW, Yi SJ (2018) association between the expression of MMP1 gene and prognosis in head and neck squamous cell carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 32(4):287–291 (Abstract)
Boström P, Soderstrom M, Vahlberg T, Soderstrom KO, Roberts PJ, Carpen O, Hirsimäki P (2011) MMP-1 expression has an independent prognostic value in breast cancer. BMC Cancer 11:348
Nguyen CH, Senfter D, Basilio J, Holzner S, Stadler S, Krieger S et al (2015) NF-kappaB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro. Oncotarget 6(36):39262–39275. https://doi.org/10.18632/oncotarget.5741
Gobin E, Bagwell K, Wagner J, Mysona D, Sandirasegarane S, Smith N, Bai S, Sharma A, Schleifer R, She JX (2019) A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. BMC Cancer 19(1):581. https://doi.org/10.1186/s12885-019-5768-0
Kuo HY, Huang YS, Tseng CH, Chen YC, Chang YW, Shih HM, Wu CW (2014) PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2. Cell Cycle 13:3132–3142
Yu Y, Ding Z, Jian H, Shen L, Zhu L, Lu S (2016) Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma. Cancer Med 5:2323–2331
De Mingo M, Moran A, Sanchez-Pernaute A, Iniesta P, Diez-Valladares L, Perez-Aguirre E, de Juan C, García-Aranda C, Díaz-López A, García-Botella A, Martín-Antona E, Benito M, Torres A, Balibrea JL (2007) Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma. Hepatogastroenterology 54:315–319
Elnemr A, Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Tochiori S, Endou Y, Sasaki T (2003) Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer 6:30–38
Sier CF, Kubben FJ, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, van Krieken JH, Lamers CB, Verspaget HW (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74:413–417
Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, Tsuruo T, Shibata Y, Muto T, Nagawa H (2000) MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist. 5(2):108–114
Gao H, Lan X, Li S, Xue Y (2017) Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. Tumour Biol 39(5):1010428317698368
Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y (2006) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26(5A):3579–3583
Guo CB, Wang S, Deng C, Zhang DL, Wang FL, Jin XQ (2007) Relationship between matrix metalloproteinase 2 and lung cancer progression. Mol Diagn Ther 11(3):183–192
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki Declaration ethical standards and approved by the Institutional Ethical Committee of Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. The study was approved by the Institutional Ethical Committee of Institute of Medical Sciences, Banaras Hindu University.
Informed Consent
Written informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kumar, P., Sebastian, A., Verma, K. et al. mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study. Indian J Surg Oncol 12 (Suppl 1), 85–92 (2021). https://doi.org/10.1007/s13193-020-01096-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-020-01096-5